SHL Telemedicine Ltd
SIX:SHLTN
SHL Telemedicine Ltd
SIX:SHLTN
Price:
3.7 CHF
Market Closed
Updated:
May 14, 2024
Section:
Relative Value
The Relative Value of one
SHLTN
stock under the Base Case scenario is
11.56
CHF.
Compared to the current market price of 3.7 CHF,
SHL Telemedicine Ltd
is
Undervalued by 68%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SHLTN
Relative Value
Base Case
11.56
CHF
Undervaluation 68%
Valuation Multiples
Multiples Across Competitors
SHLTN Competitors Multiples
SHL Telemedicine Ltd Competitors
SHL Telemedicine Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
|
SHL Telemedicine Ltd
SIX:SHLTN
|
60.6m CHF | 1.2 | -9.5 | -706.1 | -7.2 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
92.4B EUR | 0.5 | 27.5 | 9.9 | 13.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
98.6B USD | 0.5 | 27.3 | 9.9 | 13.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
69.3B USD | 0.2 | 9.5 | 8.6 | 8.6 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17.6B USD | 1.4 | 40.8 | 12.4 | 18.7 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
16.1B EUR | 0.7 | -27.2 | 10.2 | 22.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.4B USD | 1.7 | 18.3 | 10.9 | 14.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
12B EUR | 0.6 | 24 | 7 | 16.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.8B EUR | 0.6 | 23.7 | 7 | 16.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12B USD | 1 | 14.6 | 8.2 | 11.8 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
